Johnson & Johnson MedTech innovates at the intersection of biology and technology. With a focus on treating with pinpoint precision in the hardest-to-reach parts of the body, restoring anatomy and reimagining healing, our portfolio of smarter, less invasive, more personalized treatments is addressing the most complex health challenges. Healthcare areas include: Cardiovascular, Orthopaedics ...
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated and cured, treatments are smarter and less invasive and solutions are personal.
Working with Johnson & Johnson isn’t just any job. It’s an invitation to align your career with transformational breakthroughs in health. Because we’re driven by a passion to achieve the best version of health for everyone, everywhere—and existing barriers aren’t going to break themselves.
Every day, our more than 150,000 employees across the world are blending heart, science and ingenuity to profoundly change the trajectory of health for humanity.
Johnson & Johnson reports Q1 2026 results, raises 2026 outlook 2026 First-Quarter reported sales growth of 9.9% to $24.1 Billion with operational growth of 6.4%* and adjusted operational growth of 5.3%* 2026 First-Quarter earnings per share (EPS) of $2.14 and adjusted EPS of $2.70 Company increases 2026 guidance with estimated reported sales of $100.8 Billion or 7.0% at the ...
NEW BRUNSWICK, N.J.-- (BUSINESS WIRE)-- Johnson & Johnson (NYSE: JNJ) today announced results for fourth-quarter and full-year 2025. “2025 was a catapult year for Johnson & Johnson, fueled by the strongest portfolio and pipeline in our history,” said Joaquin Duato, Chairman and Chief Executive Officer, Johnson & Johnson. “Last year kicked off a new era of accelerated growth, driven by ...
Explore exciting job openings at J&J. Search global roles in healthcare and join a team committed to innovation, growth and a healthier future for all.
The brother of Johnson & Johnson cofounders Robert Wood Johnson and James Wood Johnson, Edward Mead Johnson led the company’s sales and marketing division in the 19 th century. In 1898, Edward Mead left Johnson & Johnson, taking with him the company’s digestive products line, a business that would eventually become a leading global company in the field of infant and child nutrition.
Explore Johnson & Johnson's corporate information, financial updates, and investor resources on this comprehensive platform.
New Brunswick, N.J. () — Johnson & Johnson (NYSE: JNJ) today announced results for first-quarter 2026. “ Johnson & Johnson had a strong start to 2026 and is delivering on its promise for a year of accelerated growth and impact,” said Joaquin Duato, Chairman and Chief Executive Officer, Johnson & Johnson. “The depth and strength of our portfolio and pipeline is unrivaled ...